Orthofix Medical (OFIX) Accounts Payables (2010 - 2026)

Orthofix Medical has disclosed Accounts Payables across 17 years of filings, most recently posting $54.7 million for Q1 2026.

• Quarterly Accounts Payables rose 21.05% year-over-year to $54.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.7 million (up 21.05% YoY) and the FY2025 annual result came in at $58.4 million, up 19.65% from the prior year.
• Accounts Payables fell to $54.7 million in Q1 2026, from $58.4 million in the prior quarter.
• Over five years, Accounts Payables peaked at $58.4 million in Q4 2025 and troughed at $27.4 million in Q1 2022.
• A 5-year average of $46.0 million and a median of $48.8 million in 2024 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2023 — Accounts Payables soared 111.45% — and 2025, when it declined 20.95%.
• Tracing OFIX's Accounts Payables over 5 years: stood at $27.6 million in 2022, then surged by 111.45% to $58.4 million in 2023, then decreased by 16.37% to $48.8 million in 2024, then increased by 19.65% to $58.4 million in 2025, then slipped by 6.35% to $54.7 million in 2026.
• Business Quant data shows OFIX's Accounts Payables at $54.7 million in Q1 2026, $58.4 million in Q4 2025, and $50.5 million in Q3 2025.